Onchocerciasis: Neurological involvement

Neglected Tropical Diseases and Conditions of the Nervous System

Volumn , Issue , 2014, Pages 147-164

  Njamnshi, Alfred K ^a,b   Bissek, Anne Cécile Zoung Kanyi ^a   Etya'ale, Daniel ^c  

^a UNIVERSITY OF YAOUNDÉ I   (Cameroon)

^b YAOUNDÉ CENTRAL HOSPITAL   (Cameroon)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Encephalopathy; Epilepsy; Filarial; Itch; Nematodes; Optic nerve disease; River blindness; Wolbachia

Indexed keywords

EID: 84948123652     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4614-8100-3_8     Document Type: Chapter

References (101)

1. Abiose A, Jones BR, Cousens SN, Murdoch I, Cassels-Brown A, Babalola OE, Alexander ND, Nuhu I, Evans J, Ibrahim UF et al (1993) Reduction in incidence of optic nerve disease with annual ivermectin to control onchocerciasis. Lancet 341(8838):130-134.
2. Abiose A, Murdoch I, Babalola O, Cousens S, Liman I, Onyema J, Evans J, Gregory W, Jones B (1994) Distribution and aetiology of blindness and visual impairment in mesoendemic onchocercalcommunities, Kaduna State, Nigeria. Kaduna Collaboration for Research on Onchocerciasis. Br J Ophthalmol 78(1):8-13.
3. Amazigo U, Noma M, Bump J, Benton B, Liese B, Yameogo L, Zoure H, Seketeli A (2006) Onchocerciasis. In: Jamison DT, Makgoba FR, Boser MW, Baingana FK, Hofman KJ, Rogo KO (eds) Disease and mortality in sub-Saharan Africa, 2nd edn. World Bank, Washington, DC.
4. Arborio S, Dozon JP (2000) Sociocultural dimension of epilepsy (kirikirimasien) in a Bambara rural area (Mali). Bull Soc Pathol Exot 93:241-246.
5. Babalola OE (2011) Ocular onchocerciasis: current management and future prospects. Clin Ophthalmol 5:1479-1491.
6. Bird AC, Anderson J, Fuglsang H (1976) Morphology of posterior segment lesions of the eye in patients with onchocerciasis. Br J Ophthalmol 60:2-20.
7. Bisoffi Z, Buonfrate D, Angheben A (2014) Travel, migration and neglected tropical diseases. In: Bentivoglio M, Cavalheiro EA, Kristensson K, Patel N (eds) Neglected tropical diseases and conditions of the nervous system. Springer, New York.
8. Boatin B (2008) The Onchocerciasis Control Programme in West Africa (OCP). Ann Trop Med Parasitol 102(Suppl 1):13-17.
9. Boatin BA, Richards FO Jr (2006) Control of onchocerciasis. Adv Parasitol 61:349-394.
10. Bockarie MJ, Deb RM (2010) Elimination of lymphatic filariasis: do we have the drugs to com- plete the job? Curr Opin Infect Dis 23:617-620.
11. Bourguinat C, Kamgno J, Boussinesq M, Mackenzie CD, Prichard RK, Geary TG (2010) Analysis of the mdr-1 gene in patients co-infected with Onchocerca volvulus and Loa loa who experi- enced a post-ivermectin serious adverse event. Am J Trop Med Hyg 83:28-32.
12. Boussinesq M, Gardon J, Gardon-Wendel N, Kamgno J, Ngoumou P, Chippaux JP (1998) Three probable cases of Loa loa encephalopathy following ivermectin treatment for onchocerciasis. Am J Trop Med Hyg 58:461-469.
13. Boussinesq M, Pion SD, Demanga N, Kamgno J (2002) Relationship between onchocerciasis and epilepsy: a matched case-control study in the Mbam Valley, Republic of Cameroon. Trans R Soc Trop Med Hyg 96:537-541.
14. Boussinesq M, Gardon J, Gardon-Wendel N, Chippaux JP (2003) Clinical picture, epidemiology and outcome of Loa-associated serious adverse events related to mass ivermectin treatment of onchocerciasis in Cameroon. Filaria J 2(Suppl 1):54.
15. Buguet A, Mpanzou G, Bentivoglio M (2014) Human African trypanosomiasis: a highly neglected neurological disease. In: Bentivoglio M, Cavalheiro EA, Kristensson K, Patel NB (eds) Neglected tropical diseases and conditions of the nervous system. Springer, New York Burnham G (1998) Onchocerciasis. Lancet 351:1341-1346.
16. Cevikbas F, Steinhoff M, Ikoma A (2011) Role of spinal neurotransmitter receptors in itch: new insights into therapies and drug development. CNS Neurosci Ther 17(6):742-749.
17. Coffeng LE, Fobi G, Ozoh G, Bissek AC, Nlatte BO, Enyong P, Olinga JM, Zoure HG, Habbema JD, Stolk WA, de Vlas SJ, Boussinesq M, Noma M (2012) Concurrence of dermatological and ophthalmological morbidity in onchocerciasis. Trans R Soc Trop Med Hyg 106(4):243-251.
18. Cooper PJ, Proano R, Beltran C, Anselmi M, Guderian RH (1995) Onchocerciasis in Ecuador: Ocular findings in Onchocerca volvulus infected individuals. Br J Ophthalmol 79:157-162.
19. Cousens SN, Yahaya H, Murdoch I, Samaila E, Evans J, Babalola OE, Zakari M, Abiose A, Jones BR (1997) Risk factors for optic nerve disease in communities mesoendemic for savannah onchocerciasis, Kaduna State, Nigeria. Trop Med Int Health 2:89-98.
20. Crump A, Morel CM, Omura S (2012) The onchocerciasis chronicle: From the beginning to the end? Trends Parasitol 28:280-288.
21. Dozie IN, Onwuliri CO, Nwoke BE, Chukwuocha UM, Chikwendu CI, Okoro I, Njemanze PC (2006) Onchocerciasis and epilepsy in parts of the Imo river basin, Nigeria: a preliminary report. Public Health 120:448-450.
22. Druet-Cabanac M, Preux PM, Bouteille B, Bernet-Bernady P, Dunand J, Hopkins A, Yaya G, Tabo A, Sartoris C, Macharia W, Dumas M (1999) Onchocerciasis and epilepsy: a matched case- control study in the Central African Republic. Am J Epidemiol 149:565-570.
23. Druet-Cabanac M, Boussinesq M, Dongmo L, Farnarier G, Bouteille B, Preux PM (2004) Review of epidemiological studies searching for a relationship between onchocerciasis and epilepsy. Neuroepidemiology 23:144-149.
24. Duke BO (1998) Onchocerciasis, epilepsy and hyposexual dwarfism. Trans R Soc Trop Med Hyg 92:236.
25. Ejere HO, Schwartz E, Wormald R, Evans JR (2012) Ivermectin for onchocercal eye disease (river blindness). Cochrane Database Syst Rev 8:CD002219.
26. Enk CD (2006) Onchocerciasis-river blindness. Clin Dermatol 24:176-180.
27. Etya'ale D (2001) Vision 2020: update on onchocerciasis. Community Eye Health 14:19-21.
28. Farnarier G, Diop S, Coulibaly B, Arborio S, Dabo A, Diakite M, Traore S, Banou A, Nimaga K, Vaz T, Doumbo O (2000) Onchocerciasis and epilepsy. Epidemiological survey in Mali. Med Trop (Mars) 60:151-155.
29. Furue M, Ebata T, Ikoma A, Takeuchi S, Kataoka Y, Takamori K, Satoh T, Saeki H, Augustin M, Reich A, Szepietowski J, Fleischer A, Blome C, Phan NQ, Weisshaar E, Yosipovitch G, Stander S (2013) Verbalizing extremes of the visual analogue scale for pruritus: a consensus statement. Acta Derm Venereol 93:214-215.
30. Gardon J, Gardon-Wendel N, Demanga N, Kamgno J, Chippaux JP, Boussinesq M (1997) Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection. Lancet 350:18-22.
31. Gonzalez P, Gonzalez FA, Ueno K (2012) Ivermectin in human medicine, an overview of the cur- rent status of its clinical applications. Curr Pharm Biotechnol 13:1103-1109.
32. Greaves MW, Khalifa N (2004) Itch: more than skin deep. Int Arch Allergy Immunol 135:166-172.
33. Grundmann S, Stander S (2011) Chronic pruritus: clinics and treatment. Ann Dermatol 23:1-11.
34. Hall LR, Pearlman E (1999) Pathogenesis of onchocercal keratitis (River blindness). Clin Microbiol Rev 12:445-453.
35. Han SK, Simon MI (2011) Intracellular signaling and the origins of the sensations of itch and pain. Sci Signal 4:pe38.
36. Han N, Zu JY, Chai J (2012) Spinal bombesin-recognized neurones mediate more nonhistaminer- gic than histaminergic sensation of itch in mice. Clin Exp Dermatol 37:290-295.
37. Hoerauf A, Pfarr K, Mand S, Debrah AY, Specht S (2011) Filariasis in Africa - treatment chal- lenges and prospects. Clin Microbiol Infect 17:977-985.
38. Ikoma A, Cevikbas F, Kempkes C, Steinhoff M (2011) Anatomy and neurophysiology of pruritus. Semin Cutan Med Surg 30:64-70.
39. Jeffry J, Kim S, Chen ZF (2011) Itch signaling in the nervous system. Physiology (Bethesda) 26:286-292.
40. Kabore JK, Cabore JW, Melaku Z, Druet-Cabanac M, Preux PM (1996) Epilepsy in a focus of onchocerciasis in Burkina Faso. Lancet 347:836.
41. Kaiser C, Kipp W, Asaba G, Mugisa C, Kabagambe G, Rating D, Leichsenring M (1996) The prevalence of epilepsy follows the distribution of onchocerciasis in a west Ugandan focus. Bull World Health Organ 74:361-367.
42. Kaiser C, Asaba G, Leichsenring M, Kabagambe G (1998) High incidence of epilepsy related to onchocerciasis in West Uganda. Epilepsy Res 30:247-251.
43. Kaiser C, Benninger C, Asaba G, Mugisa C, Kabagambe G, Kipp W, Rating D (2000) Clinical and electro-clinical classification of epileptic seizure in west Uganda. Bull Soc Pathol Exot 93:255-259.
44. Kaiser C, Asaba G, Kasoro S, Rubaale T, Kabagambe G, Mbabazi M (2007) Mortality from epi- lepsy in an onchocerciasis-endemic area in West Uganda. Trans R Soc Trop Med Hyg 101:48-55.
45. Kaiser C, Pion S, Preux PM, Kipp W, Dozie I, Boussinesq M (2008) Onchocerciasis, cysticercosis, and epilepsy. Am J Trop Med Hyg 79:643-644,.
46. Kaiser C, Pion S, Boussinesq M (2009) Head nodding syndrome and river blindness: a parasito- logic perspective. Epilepsia 50:2325-2326.
47. Kaiser C, Pion S, Boussinesq M (2010) Do helminths cause epilepsy? The case of Onchocerca volvulus. Parasite Immunol 32:79-80.
48. Kaiser C, Rubaale T, Tukesiga E, Kipp W, Kabagambe G, Ojony JO, Asaba G (2011) Association between onchocerciasis and epilepsy in the Itwara hyperendemic focus, West Uganda: control- ling for time and intensity of exposure. Am J Trop Med Hyg 85:225-228.
49. Kaiser C, Rubaale T, Ojony JO, Asaba G, Tukesiga E, Kipp W, Kabagambe G (2012) In response: a call for more case-controlled studies on onchocerciasis and epilepsy. Am J Trop Med Hyg 86:558.
50. Kamgno J, Gardon J, Boussinesq M (2000) Analysis of the prevention of post-ivermectin Loa loa encephalopathy by administration of initial low dose. Med Trop (Mars) 60:275-277.
51. Kamgno J, Pion SD, Boussinesq M (2003) Demographic impact of epilepsy in Africa: results of a 10-year cohort study in a rural area of Cameroon. Epilepsia 44:956-963.
52. Kamgno J, Boussinesq M, Labrousse F, Nkegoum B, Thylefors BI, Mackenzie CD (2008) Encephalopathy after ivermectin treatment in a patient infected with Loa loa and Plasmodium spp Am J Trop Med Hyg 78:546-551.
53. Kanmogne GD, Kuate CT, Cysique LA, Fonsah JY, Eta S, Doh R, Njamnshi DM, Nchindap E, Franklin DR Jr, Ellis RJ, McCutchan JA, Binam F, Mbanya D, Heaton RK, Njamnshi AK (2010) HIV-associated neurocognitive disorders in sub-Saharan Africa: a pilot study in Cameroon. BMC Neurol 10:60. doi:10.1186/1471-2377-10-60.
54. Katabarwa M, Lakwo T, Habumogisha P, Richards F, Eberhard M (2008) Could neurocysticercosis be the cause of “onchocerciasis-associated” epileptic seizures? Am J Trop Med Hyg 78:400-401.
55. Keiser PB, Reynolds SM, Awadzi K, Ottesen EA, Taylor MJ, Nutman TB (2002) Bacterial endo- symbionts of Onchocerca volvulus in the pathogenesis of posttreatment reactions. J Infect Dis 15:805-811.
56. Kilian AH (1994) Onchocerciasis and epilepsy. Lancet 343:983.
57. Kipp W, Burnham G, Kamugisha J (1992) Improvement in seizures after ivermectin. Lancet 340:789-790.
58. Kipp W, Kasoro S, Burnham G (1994) Onchocerciasis and epilepsy in Uganda. Lancet 343:183-184.
59. Koga K, Chen T, Li XY, Descalzi G, Ling J, Gu J, Zhuo M (2011) Glutamate acts as a neurotrans- mitter for gastrin releasing peptide-sensitive and insensitive itch-related synaptic transmission in mammalian spinal cord. Mol Pain 7:47. doi: 10.1186/1744-8069-7-47.
60. Konig R, Nassri A, Meindl M, Matuja W, Kidunda AR, Siegmund V, Bretzel G, Loscher T, Jilek- Aall L, Schmutzhard E, Winkler AS (2010) The role of Onchocerca volvulus in the develop- ment of epilepsy in a rural area of Tanzania. Parasitology 137:1559-1568.
61. Mackenzie CD, Homeida MM, Hopkins AD, Lawrence JC (2012) Elimination of onchocerciasis from Africa: possible? Trends Parasitol 28:16-22.
62. Maegga B (1998) Onchocerciasis in Tanzania. Sante 8:49-50.
63. Marin B, Boussinesq M, Druet-Cabanac M, Kamgno J, Bouteille B, Preux PM (2006) Onchocerciasis-related epilepsy? Prospects at a time of uncertainty. Trends Parasitol 22:17-20.
64. Mbanefo EC, Eneanya CI, Nwaorgu OC, Oguoma VM, Otiji MO, Ogolo BA (2010) Onchocerciasis in Anambra State, Southeast Nigeria: clinical and psychological aspects and sustainability of community directed treatment with ivermectin (CDTI). Postgrad Med J 86:573-577.
65. Mckechnie NM, Gurr W, Braun G (1997) Immunization with the cross-reactive antigens Ov39 from Onchocerca volvulus and hr44 from human retinal tissue induces ocular pathology and activates retinal microglia. J Infect Dis 176:1334-1343.
66. Moussala M, Fobi G, Ongolo-Zogo P, Bella Hiag LA, Bengono G, McMoli TE (2004) Retinal hemorrhages after ivermectin treatment for onchocerciasis in a patient with Loa loa microfila- remia. J Fr Ophtalmol 27:63-66.
67. Murdoch ME (2010) Onchodermatitis. Curr Opin Infect Dis 23:124-131.
68. Murdoch ME, Payton A, Abiose A, Thomson W, Panicker VK, Dyer PA, Jones BR, Maizels RM, Ollier WE (1997) HLA-DQ alleles associate with cutaneous features of onchocerciasis. The Kaduna-London-Manchester Collaboration for Research on Onchocerciasis. Hum Immunol 55:46-52.
69. Nakano T, Andoh T, Lee JB, Kuraishi Y (2008) Different dorsal horn neurons responding to hista- mine and allergic itch stimuli. Neuroreport 19:723-726.
70. Nana-Djeunga HBC, Pion SD, Kamgno J, Gardon J, Njiokou F, Boussinesq M, Prichard RK (2012) Single nucleotide polymorphisms in p-tubulin selected in Onchocerca volvulus follow- ing repeated ivermectin treatment: possible indication of resistance selection. Mol Biochem Parasitol 185:10-18.
71. Newell ED, Vyungimana F, Bradley JE (1997) Epilepsy, retarded growth and onchocerciasis, in two areas of different endemicity of onchocerciasis in Burundi. Trans R Soc Trop Med Hyg 91:525-527.
72. Njamnshi AK, Sini V, Djientcheu V de P, Ongolo-Zogo P, Mapoure N, Yepnjio FN, Echouffo TJB, Zebaze R, Meli J, Atchou G, Dongmo L, Muna W (2007) Risk factors associated with epilepsy in a rural area in Cameroon: a preliminary study. Afr J Neurol Sci 26(2):18-26.
73. Njamnshi AK, Djientcheu Vde P, Fonsah JY, Yepnjio FN, Njamnshi DM, Muna WE (2008) The International HIV Dementia Scale is a useful screening tool for HIV-associated dementia/cog- nitive impairment in HIV-infected adults in Yaounde-Cameroon. J Acquir Immune Defic Syndr 49(4):393-397.
74. Njamnshi AK, Perrig S, Seke Etet PF, Acho A, Fonsah JY, Mumba DN, Muyembe J-J Kristensson K, Bentivoglio M (2012) Actigraphy in human African trypanosomiasis: A new tool to evaluate disease severity. PLoS Negl Trop Dis 6:e1525.
75. Osei-Atweneboana MY, Awadzi K, Attah SK, Boakye DA, Gyapong JO, Prichard RK (2011) Phenotypic evidence of emerging ivermectin resistance in Onchocerca volvulus. PLoS Negl Trop Dis 5:e998. doi:10.1371/journal.pntd.0000998.
76. Ovuga E, Kipp W, Mungherera M, Kasoro S (1992) Epilepsy and retarded growth in a hyperen-demic focus of onchocerciasis in rural western Uganda. East Afr Med J 69:554-556.
77. Ozoh GA, Murdoch ME, Bissek AC, Hagan M, Ogbuagu K, Shamad M, Braide EI, Boussinesq M, Noma MM, Murdoch IE, Seketeli A, Amazigo UV (2011) The African Programme for Onchocerciasis Control: impact on onchocercal skin disease. Trop Med Int Health 16:875-883.
78. Papoiu A, Wang H, Coghill R, Chan YH, Yosipovitch G (2011) Contagious itch in humans. A study of visual “transmission” of itch in atopic dermatitis and healthy subjects. Br J Dermatol 164:1299-1303.
79. Paus R, Schmelz M, Biro T, Steinhoff M (2006) Frontiers in pruritus research: scratching the brain for more effective itch therapy. J Clin Invest 116:1174-1186.
80. Pfab F, Valet M, Napadow V, Tolle TR, Behrendt H, Ring J, Darsow U (2012) Itch and the brain. Chem Immunol Allergy 98:253-265.
81. Phan NQ, Blome C, Fritz F, Gerss J, Reich A, Ebata T, Augustin M, Szepietowski JC, Stander S (2011) Assessment of pruritus intensity: prospective study on validity and reliability of the visual analogue scale, numerical rating scale and verbal rating scale in 471 patients with chronic pruritus. Acta Derm Venereol 92:502-507.
82. Pion SD, Boussinesq M (2012) Significant association between epilepsy and presence of oncho- cercal nodules: case-control study in Cameroon. Am J Trop Med Hyg 86:557.
83. Pion SD, Kaiser C, Boutros-Toni F, Cournil A, Taylor MM, Meredith SE, Stufe A, Bertocchi I, Kipp W, Preux PM, Boussinesq M (2009) Epilepsy in onchocerciasis endemic areas: system- atic review and meta-analysis of population-based surveys. PLoS Negl Trop Dis 3:e461.
84. Prischich F, De Rinaldis M, Bruno F, Egeo G, Santori C, Zappaterreno A, Di Fattouch J, Bonaventura C, Bada J, Russo G, Pizzuti A, Cardona F, Sa'a Vullo V, Giallonardo AT, D'erasmo E, Pelliccia A, Vanacore N (2008) High prevalence of epilepsy in a village in the Littoral Province of Cameroon. Epilepsy Res 82:200-210.
85. Reich A, Heisig M, Phan NQ, Taneda K, Takamori K, Takeuchi S, Furue M, Blome C, Augustin M, Stander S, Szepietowski JC (2011) Visual analogue scale: evaluation of the instrument for the assessment of pruritus. Acta Derm Venereol 92:497-501.
86. Ringkamp M, Schepers RJ, Shimada SG, Johanek LM, Hartke TV, Borzan J, Shim B, LaMotte RH, Meyer RA (2011) A role for nociceptive, myelinated nerve fibers in itch sensation. J Neurosci 31(42):14841-14849.
87. Sacktor NC, Wong M, Nakasujja N, Skolasky RL, Seines OA, Musisi S, Robertson K, McArthur JC, Ronald A, Katabira E (2005) The International HIV Dementia Scale: a new rapid screening test for HIV dementia. AIDS 19:1367-1374.
88. Sauerbrey M (2008) The Onchocerciasis Elimination Program for the Americas (OEPA). Ann Trop Med Parasitol 102(Suppl 1):25-29.
89. Siddiqui MA, Al-Khawajah MM (1991) The black disease of Arabia. Sowda-onchocerciasis. New findings. Int J Dermatol 30:130-133.
90. Sun YG, Zhao ZQ, Meng XL, Yin J, Liu XY, Chen ZF (2009) Cellular basis of itch sensation. Science 325:1531-1534.
91. Tabah EN, Yepnjio FN, Njamnshi AK (2014) Stigma in neurological diseases in the tropics. In: Bentivoglio M, Cavalheiro EA, Kristensson K, Patel N (eds) Neglected tropical diseases and conditions of the nervous system. Springer, New York.
92. Takesue AHY, Ono K, Murakami A (2012) Towards the elimination of onchocerciasis at the global scale: history, challenges and future prospects. Nihon Ganka Gakkai Zasshi 116:547-553.
93. Tamarozzi F, Halliday A, Gentil K, Hoerauf A, Pearlman E, Taylor MJ (2011) Onchocerciasis: the role of Wolbachia bacterial endosymbionts in parasite biology, disease pathogenesis, and treat- ment. Clin Microbiol Rev 24:459-468.
94. Tey HL, Yosipovitch G (2011) Targeted treatment of pruritus: a look into the future. Br J Dermatol 165:5-17.
95. Thylefors B (2008) The Mectizan Donation Program (MDP). Ann Trop Med Parasitol 102:39-44.
96. Twum-Danso NA (2004) Mass treatment of onchocerciasis with ivermectin: should people with epilepsy and/or growth-retardation syndromes be excluded? Ann Trop Med Parasitol 98:99-114.
97. Umeh RE, Chijioke CP, Okonkwo PO (1996) Eye disease in an onchocerciasis-endemic area of the forest-savanna mosaic region of Nigeria. Bull World Health Organ 74:95-100.
98. World Health Organisation (2010) First report on neglected tropical diseases: working to overcome the global impact of neglected tropical diseases. WHO Press, WHO, 20 Av Appia, Geneva.
99. Williams SC (2012) Nodding syndrome leaves baffled scientists shaking their heads. Nat Med 18:334.
100. Winkler AS, Friedrich K, Konig R, Meindl M, Helbok R, Unterberger I, Gotwald T, Dharsee J, Velicheti S, Kidunda A, Jilek-Aall L, Matuja W, Schmutzhard E (2008) The head nodding syndrome-clinical classification and possible causes. Epilepsia 49:2008-2015.
101. Yang YF, Cousens S, Murdoch IE, Babalola OE, Abiose A, Jones B (2001) Intraocular pressure and gonioscopic findings in rural communities mesoendemic and nonendemic for onchoceria- sis, Kaduna State, Nigeria. Eye (Lond) 15:756-759.